Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.46 EUR | +0.64% | +0.42% | -14.00% |
Apr. 19 | ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red. | AN |
Apr. 18 | Intred appoints new board of directors; Daniele Peli chairman and Ad | AN |
Valuation
Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 299.6 | 229.3 | 150.2 | - | - |
Enterprise Value (EV) 1 | 294.2 | 240.8 | 179.4 | 176.5 | 169.2 |
P/E ratio | 34.8 x | 26.4 x | 22.6 x | 20 x | 17 x |
Yield | - | 0.48% | 0.8% | 0.92% | 1.29% |
Capitalization / Revenue | 7.4 x | 5.04 x | 2.61 x | 2.34 x | 2.08 x |
EV / Revenue | 7.27 x | 5.29 x | 3.12 x | 2.75 x | 2.35 x |
EV / EBITDA | 16.7 x | 12.1 x | 7.52 x | 6.52 x | 5.4 x |
EV / FCF | 14.3 x | -14.6 x | -57.3 x | 38.8 x | 16.1 x |
FCF Yield | 7.01% | -6.84% | -1.75% | 2.58% | 6.21% |
Price to Book | - | 4.78 x | 2.51 x | 2.29 x | 2.07 x |
Nbr of stocks (in thousands) | 15,851 | 15,865 | 15,873 | - | - |
Reference price 2 | 18.90 | 14.45 | 9.460 | 9.460 | 9.460 |
Announcement Date | 3/28/22 | 3/27/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | 40.46 | 45.52 | 57.57 | 64.1 | 72.05 |
EBITDA 1 | - | 17.6 | 19.9 | 23.87 | 27.07 | 31.3 |
EBIT 1 | - | - | 12.16 | 11.2 | 12.93 | 16.2 |
Operating Margin | - | - | 26.72% | 19.46% | 20.18% | 22.48% |
Earnings before Tax (EBT) 1 | 8.181 | - | 12.18 | 10 | 11.65 | 14.65 |
Net income 1 | 6.111 | 8.62 | 8.675 | 6.967 | 8.083 | 10.32 |
Net margin | - | 21.31% | 19.06% | 12.1% | 12.61% | 14.33% |
EPS 2 | - | 0.5439 | 0.5468 | 0.4190 | 0.4735 | 0.5560 |
Free Cash Flow 1 | - | 20.63 | -16.48 | -3.133 | 4.55 | 10.5 |
FCF margin | - | 51% | -36.2% | -5.44% | 7.1% | 14.57% |
FCF Conversion (EBITDA) | - | 117.23% | - | - | 16.81% | 33.55% |
FCF Conversion (Net income) | - | 239.34% | - | - | 56.29% | 101.69% |
Dividend per Share 2 | - | - | 0.0700 | 0.0760 | 0.0870 | 0.1220 |
Announcement Date | 7/22/21 | 3/28/22 | 3/27/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 S1 | 2022 S2 | 2023 S1 |
---|---|---|---|
Net sales 1 | 23.35 | 22.17 | 24.7 |
EBITDA | - | - | - |
EBIT | - | - | - |
Operating Margin | - | - | - |
Earnings before Tax (EBT) | - | 6.032 | - |
Net income 1 | 4.267 | 4.408 | 3.901 |
Net margin | 18.28% | 19.88% | 15.79% |
EPS | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 9/30/22 | 3/27/23 | 9/27/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 11.5 | 29.3 | 26.3 | 19 |
Net Cash position 1 | - | 5.41 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.5795 x | 1.226 x | 0.9719 x | 0.6069 x |
Free Cash Flow 1 | - | 20.6 | -16.5 | -3.13 | 4.55 | 10.5 |
ROE (net income / shareholders' equity) | - | - | 19.7% | 11.2% | 11.5% | 12.8% |
ROA (Net income/ Total Assets) | - | - | 8.19% | 4.9% | 5.2% | - |
Assets 1 | - | - | 105.9 | 142.2 | 155.4 | - |
Book Value Per Share 2 | - | - | 3.030 | 3.770 | 4.130 | 4.570 |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | - | 39.3 | 26.5 | 18.6 | 16.1 |
Capex / Sales | - | - | 86.43% | 46% | 29.07% | 22.28% |
Announcement Date | 7/22/21 | 3/28/22 | 3/27/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.00% | 160M | |
+9.65% | 199B | |
+5.25% | 167B | |
+0.46% | 116B | |
-2.38% | 89.84B | |
+17.65% | 72.93B | |
+2.80% | 58.42B | |
-5.07% | 50.97B | |
-13.54% | 40.2B | |
-34.49% | 35B |
- Stock Market
- Equities
- ITD Stock
- Financials Intred S.p.A.